Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. QIAGEN N.V.
  6. News
  7. Summary
    QGEN   NL0012169213

QIAGEN N.V.

(QGEN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

09/17/2021 | 04:04pm EDT

DGAP Voting Rights Announcement: QIAGEN N.V.
QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

17.09.2021 / 22:03
Dissemination of a Voting Rights Announcement transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


The AFM (the Netherlands Authority For the Financial Markets) has informed us on September 15, 2021 that a notification related to our institution has been released by the AFM.

The following notification has been disclosed in the relevant register on the AFM website:

Date of transaction: 13 sep 2021
Person obliged to notify: BlackRock, Inc.
Issuing institution: Qiagen N.V.
Registration Chamber of Commerce: 12036979
Place of residence: VENLO

Distribution in numbers

Type of share Number of shares Number of voting rights Capital interest Voting rights Manner of disposal Settlement
Ordinary share 32.909.366,00 35.400.723,00 Real Real Indirectly - BlackRock, Inc.  
Contract for difference 117.211,00 117.211,00 Potential Potential Indirectly - BlackRock, Inc. In Cash
Ordinary share 749.676,00 749.676,00 Potential Potential Indirectly - BlackRock, Inc. Physical Delivery
 


Distribution in percentages

Type Total holding Directly real Directly potential Indirectly real Indirectly potential
Capital interest 14,63 % 0,00 % 0,00 % 14,26 % 0,38 %
Voting rights 15,71 % 0,00 % 0,00 % 15,34 % 0,38 %
 

QIAGEN N.V. is not responsible for the accuracy and correctness of the notification above. The content has been taken from the relevant register of the AFM: https://www.afm.nl/en/professionals/registers/meldingenregisters/substantiele-deelnemingen/details?id=115620



17.09.2021 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: QIAGEN N.V.
Hulsterweg 82
5912 PL Venlo
Netherlands
Internet: www.qiagen.com

 
End of News DGAP News Service

1233599  17.09.2021 

fncls.ssp?fn=show_t_gif&application_id=1233599&application_name=news&site_id=zonebourse_sftp

© EQS 2021
All news about QIAGEN N.V.
06:45aQIAGEN N : Completes Transfer of Precision Medicine Research Operations to Manchester
MT
06:01aQIAGEN N : Strengthens UK Footprint With Move to New Manchester Facilities
BU
10/20QIAGEN N.V. : to Release Results for Q3 2021 and First Nine Months of 2021
BU
10/19QIAGEN N : Launches QIAreach Quanti-FERON-TB for TB Testing in High Burden Regions
MT
10/19QIAGEN N : Launches Novel QIAreach QuantiFERON-TB Tuberculosis Test for High-Burden Region..
BU
10/19QIAGEN N.V. Launches Novel QIAreach QuantiFERON-TB Tuberculosis Test for High-Burden Re..
CI
10/19QIAGEN N.V. : Release of a capital market information
EQ
10/19QIAGEN N.V. : Release of a capital market information
DJ
10/14QIAGEN N : Redburn Starts Qiagen NV at Buy
MT
10/12QIAGEN N.V. : Release of a capital market information
DJ
More news
Analyst Recommendations on QIAGEN N.V.
More recommendations
Financials (USD)
Sales 2021 2 157 M - -
Net income 2021 449 M - -
Net Debt 2021 942 M - -
P/E ratio 2021 27,2x
Yield 2021 -
Capitalization 12 147 M 12 147 M -
EV / Sales 2021 6,07x
EV / Sales 2022 6,23x
Nbr of Employees 5 900
Free-Float 98,3%
Chart QIAGEN N.V.
Duration : Period :
QIAGEN N.V. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends QIAGEN N.V.
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 14
Last Close Price 53,56 $
Average target price 55,96 $
Spread / Average Target 4,48%
EPS Revisions
Managers and Directors
Thierry Bernard Chief Executive Officer & Managing Director
Roland Sackers Chief Financial Officer & Managing Director
Lawrence A. Rosen Chairman-Supervisory Board
Barthold Piening Senior Vice President & Head-Global Operations
Metin Colpan Independent Member-Supervisory Board
Sector and Competitors
1st jan.Capi. (M$)
QIAGEN N.V.1.34%12 147
MODERNA, INC.225.04%137 066
LONZA GROUP AG32.03%60 786
IQVIA HOLDINGS INC.42.23%48 830
SEAGEN INC.-0.71%31 638
CELLTRION, INC.-39.42%25 233